MARTI, Matteo
 Distribuzione geografica
Continente #
NA - Nord America 8.924
EU - Europa 3.964
AS - Asia 2.004
SA - Sud America 26
OC - Oceania 20
AF - Africa 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 14.948
Nazione #
US - Stati Uniti d'America 8.831
IT - Italia 1.864
CN - Cina 807
SG - Singapore 637
DE - Germania 524
UA - Ucraina 506
TR - Turchia 308
GB - Regno Unito 268
FI - Finlandia 256
RO - Romania 110
SE - Svezia 106
ID - Indonesia 104
NL - Olanda 85
CA - Canada 81
FR - Francia 54
PL - Polonia 41
BE - Belgio 38
IN - India 26
CZ - Repubblica Ceca 23
JP - Giappone 22
AU - Australia 19
LT - Lituania 19
HK - Hong Kong 18
IR - Iran 18
BR - Brasile 16
ES - Italia 16
RU - Federazione Russa 14
UZ - Uzbekistan 10
CH - Svizzera 9
PK - Pakistan 9
AT - Austria 8
HU - Ungheria 7
KR - Corea 7
AE - Emirati Arabi Uniti 6
MX - Messico 6
MY - Malesia 6
VN - Vietnam 6
PE - Perù 5
PT - Portogallo 5
CL - Cile 4
IL - Israele 4
PH - Filippine 4
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BD - Bangladesh 2
DK - Danimarca 2
EU - Europa 2
GR - Grecia 2
IE - Irlanda 2
JM - Giamaica 2
PA - Panama 2
SM - San Marino 2
TH - Thailandia 2
AZ - Azerbaigian 1
BG - Bulgaria 1
CO - Colombia 1
CR - Costa Rica 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
KH - Cambogia 1
KZ - Kazakistan 1
MA - Marocco 1
NZ - Nuova Zelanda 1
OM - Oman 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TZ - Tanzania 1
ZA - Sudafrica 1
Totale 14.948
Città #
Fairfield 1.078
Woodbridge 978
Santa Clara 646
Ashburn 634
Chandler 604
Houston 589
Jacksonville 539
Singapore 511
Seattle 411
Ann Arbor 393
Wilmington 388
Cambridge 378
Ferrara 261
Beijing 195
Izmir 193
Munich 184
Milan 174
Princeton 158
Helsinki 156
Nanjing 141
Shanghai 136
Boardman 110
San Diego 107
Jakarta 94
New York 89
Rome 71
Redwood City 68
Los Angeles 53
Bologna 52
Bremen 43
Hebei 42
Shenyang 40
Falls Church 36
Brussels 33
London 32
Warsaw 32
Nanchang 27
Norwalk 27
Tianjin 27
Toronto 27
Mountain View 26
Washington 26
Jiaxing 25
Ottawa 24
Cagliari 23
Florence 22
San Mateo 22
Changsha 20
Auburn Hills 19
Brno 19
Leawood 18
Falkenstein 17
Hong Kong 15
Dearborn 14
Augusta 13
Jinan 13
Turin 13
Ardabil 12
Zhengzhou 12
Frankfurt am Main 11
Kunming 11
Naples 11
Palermo 11
Verona 11
Catania 10
Redmond 10
Tokyo 10
Venice 10
Clifton Park 9
Guangzhou 9
San Jose 9
Serra 9
Tappahannock 9
Tashkent 9
Guarda Veneta 8
Mississauga 8
Padova 8
Taizhou 8
Timisoara 8
Winchester 8
Amsterdam 7
Brescia 7
Chicago 7
Genoa 7
Indiana 7
Minerbe 7
Modena 7
Ningbo 7
North Bergen 7
Orange 7
Pune 7
Daly City 6
Dong Ket 6
Salt Lake City 6
Adelaide 5
Bandung 5
Bari 5
Brusaporto 5
Charlton 5
Dubai 5
Totale 10.432
Nome #
Effetti acuti di JWH-018 e dei suoi sostituti alogenati sulle funzioni sensori-motorie del topo 694
Dall’America all’Asia: Salvia divinorum e Mitragyna speciosa 500
Autoerotic death: un unusual case of lethal asphyxiophilia associated with autogynephilia 320
Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on “tetrad”, sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies 247
1‐cyclohexyl‐x‐methoxybenzene derivatives, novel psychoactive substances seized on the internet market. Synthesis and in vivo pharmacological studies in mice 216
[Nphe(1),Arg(14),Lys(15)]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor 206
Acute and chronic antiparkinsonian effects of the novel nociceptin/orphanin FQ receptor antagonist NiK-21273 in comparison with SB-612111 195
Synthetic cannabinoid JWH-018 and its halogenated derivatives JWH-018-Cl and JWH-018-Br impair Novel Object Recognition in mice: Behavioral, electrophysiological and neurochemical evidence 193
Novel halogenated derivates of JWH-018: Behavioral and binding studies in mice 189
Forensic DNA phenotyping: prediction of human externally visible traits in missing person identification 189
Effect of JWH-250, JWH-073 and their interaction on “tetrad”, sensorimotor, neurological and neurochemical responses in mice 174
Stimulation OF IN VIVO dopamine transmission and intravenous self-administration in rats and mice by JWH-018, a Spice cannabinoid 159
Molecular imaging for the evaluation of drug-–receptor interactions in psycoactive substances of abuse 157
Psychostimulant effect of the synthetic cannabinoid JWH-018 and AKB48. Behavioural, neurochemical and Dopamine transporter scan imaging studies in mice 152
Behavioral and neurochemical rewarding properties of a cannabinoid compound of Spice drugs: JWH-018 148
The Cathinones MDPV and α-PVP Elicit Different Behavioral and Molecular Effects Following Acute Exposure 144
Loss of cortical GABA terminals in Unverricht–Lundborg disease 136
MDMA alone affects sensorimotor and prepulse inhibition responses in mice and rats: tips in the debate on potential MDMA unsafety in human activity 136
Amantadine attenuates levodopa-induced dyskinesia in mice and rats preventing the accompanying rise in nigral GABA levels 135
The nociceptin/orphanin FQ receptor antagonist J-113397 and L-DOPA additively attenuate experimental parkinsonism through overinhibition of the nigrothalamic pathway 132
Pharmacological profile of nociceptin/orphanin FQ receptors regulating 5-hydroxytryptamine release in the mouse neocortex 130
Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior 129
Urinary excretion profile of methiopropamine in mice following intraperitoneal administration: A liquid chromatography–tandem mass spectrometry investigation 128
In vivo evidence for a differential contribution of striatal and nigral D1 and D2 receptors to L-DOPA induced dyskinesia and the accompanying surge of nigral amino acid levels 128
Dopamine-nociceptin/orphanin FQ interactions in the substantia nigra reticulata of hemiparkinsonian rats: Involvement of D2/D3 receptors and impact on nigro-thalamic neurons and motor activity 125
Nociceptin/Orphanin FQ Receptor Agonists Attenuate L-DOPA-Induced Dyskinesias 124
Neurological, sensorimotor and cardiorespiratory alterations induced by methoxetamine, ketamine and phencyclidine in mice 124
Un distillato Bohémienne tuttora famoso: l’assenzio 122
Antagonism of metabotropic glutamate receptor type 5 attenuates L-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson's disease 121
Striatal glutamate release evoked in vivo by NMDA is dependent upon ongoing neuronal activity in the substantia nigra, endogenous striatal substance P and dopamine 121
null 121
Nociceptin/orphanin FQ receptor knockout rats: In vitro and in vivo studies 119
Cocaine modulates allosteric D2-σ1 receptor-receptor interactions on dopamine and glutamate nerve terminals from rat striatum 119
JWH-018 impairs sensorimotor functions in mice 118
NMDA and non-NMDA ionotropic glutamate receptors modulate striatal acetylcholine release via pre- and postsynaptic mechanisms 117
Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease 117
Striatal Dopamine-NMDA receptor interactions in the modulation of glutamate release in the substantia nigra pars reticulata in vivo: opposite role for D1 and D2 receptors 116
Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's disease 116
Differential responsiveness of rat striatal nerve endings to the mitochondrial toxin 3-nitropropionic acid: implications for Huntington’s disease 116
Plasticity of glutamatergic control of striatal acetylcholine release in experimental parkinsonism: opposite changes at group-II metabotropic and NMDA receptors 115
Pharmaco-toxicological effects of the novel third-generation fluorinate synthetic cannabinoids, 5F-ADBINACA, AB-FUBINACA, and STS-135 in mice. In vitro and in vivo studies 115
Acute and repeated administration of MDPV increases aggressive behavior in mice: forensic implications 115
Antagonisti dei recettori NOP e loro usi terapeutici 114
Changes of glutamatergic control of striatal acetylcholine release in experimental parkinsonism 114
null 113
Pharmacological profiles of presynaptic nociceptin/orphanin FQ receptors modulating 5-hydroxytryptamine and noradrenaline release in the rat neocortex. 112
Pharmacological and genetic evidence for pre- and postsynaptic D2 receptor involvement in motor responses to nociceptin/orphanin FQ receptor ligands 112
Lamotrigine and remacemide protect striatal neurons against in vitro ischemia: An electrophysiological study 108
null 108
Identification of MT-45 Metabolites: In Silico Prediction, In Vitro Incubation with Rat Hepatocytes and In Vivo Confirmation 108
Increased responsivity of glutamate release from the substantia nigra pars reticulata to striatal NMDA receptor blockade in a model of Parkinson's disease. A dual probe microdialysis study in hemiparkinsonian rats 106
Presynaptic group I and II metabotropic glutamate receptors oppositely modulate striatal acetylcholine release 105
Novel Synthetic Opioids: The Pathologist's Point of View 103
Nociceptin/orphanin FQ receptors modulate glutamate extracellular levels in the substantia nigra pars reticulata: A microdialysis study in the awake freely moving rat. 99
Novel halogenated synthetic cannabinoids impair sensorimotor functions in mice 96
Metabotropic glutamate 2 receptors modulate synaptic inputs and calcium signals in striatal cholinergic interneurons 96
Evidence for a striatal NMDA receptor modulation of nigral glutamate release. A dual probe microdialysis study in the awake freely moving rat 95
null 94
Nociceptin/orphanin FQ receptors modulate locomotion and motor cortex excitability in adult Rats 93
Ayahuasca: il vino dell'anima 93
Cutaneous miRNAs expression in human hanging injuries 93
null 92
null 92
L-dopa-induced dyskinesia: beyond an excessive dopamine tone in the striatum 91
null 91
Differential role of striatal and nigral D1receptors in the expression of L-DOPA induced dyskinesia and its neurochemical correlates 91
Phenotypic effects of chronic and acute use of methiopropamine in a mouse model 90
Modulation of 5-hydroxytryptamine efflux from rat cortical synaptosomes by opioids and nociceptin 89
JWH-018 and its N-pentyl-halogenated derivates impair sensory motor functions in mice. 89
null 89
null 88
Pharmacological and behavioral effects of the synthetic cannabinoid AKB48 in rats 88
Application of 13 loci STR multiplex for the cannabis sativa genotyping 88
null 87
null 87
Blockade of nociceptin/orphanin FQ transmission in rat substantia nigra reverses haloperidol-induced akinesia and normalizes nigral glutamate release 87
Kindled seizure-evoked somatostatin release in the hippocampus: inhibition by MK-801 86
Droghe da stupro: il GHB ed i suoi analoghi 86
Direct and indirect inhibition by nociceptin/orphanin FQ on noradrenaline release from rodent cerebral cortex in vitro 86
Reply to "MDPV-induced aggression in humans not established" 85
Agonisti dei recettori NOP per il trattamento delle discinesie da levodopa; 84
Nanostructured lipid carriers as delivery systems for parkinson’s therapy 84
null 84
Application of 13 loci STR multiplex for cannabis sativa genotyping 84
Forensic DNA Phenotyping (FDP): A Prediction of Human Externally Visible Traits in Missing Person Identification 83
null 82
Studio degli effetti acuti e cronici e delle proprietà d’abuso del cannabinoide sintetico JWH-018: un approccio multidisciplinare 79
DNA recovery from immunochromatographic membranes 79
Synthetic cannabinoid JWH-018 impairs object recognition memory in mice: behavioral and electrophysiological evidence 79
L-glutamate and gamma-aminobutyric acid efflux from rat cerebrocortical synaptosomes: Modulation by kappa- and mu- but not delta- and opioid receptor like-1 receptors 78
Regulation of miRNAs as new tool for cutaneous vitality lesions demonstration in ligature marks in deaths by hanging 75
Nociceptin/orphanin FQ receptor antagonists riverse akinesia in rat parkinsonian models 71
Mrna profiling in casework analyses 71
Nociceptin/orphanin FQ receptor antagonists reverse parkinsonism in MPTP-treated mice and non-human primates 70
Novel therapeutic strategies for treatment of motor abnormalities in Parkinson’s disease: focus on opioid receptors 70
L-DOPA-induced modulation of GABA and glutamate release in the substantia nigra pars reticulata and globus pallidus in a rat model of dyskinesia 69
Reciprocal dopamine-glutamate modulation of release in the basal ganglia 67
Studio multidisciplinare degli effetti farmaco-tossicologici e fisiopatologici di nuove molecole psicoattive sintetiche (novel synthetic drugs, ns-drugs) per comprendere le possibili alterazioni psico-fisiche nei guidatori di autoveicoli 67
Neurochemical and behavioral profiling in male and female rats of the psychedelic agent 25I-NBOMe 67
Nociceptin/orphanin FQ receptor antagonists as a novel therapeutic approach to Parkinson’s disease: interaction with levodopa 66
Totale 12.231
Categoria #
all - tutte 77.483
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 906
Totale 78.389


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.180 0 0 0 0 0 0 206 245 229 245 190 65
2020/20212.265 179 137 190 247 165 176 96 283 84 294 271 143
2021/20221.501 79 181 124 52 87 66 99 69 45 105 144 450
2022/20231.602 179 145 81 150 232 177 104 133 226 28 93 54
2023/20241.386 96 105 65 48 123 204 76 107 56 82 77 347
2024/20252.830 206 174 532 318 550 749 301 0 0 0 0 0
Totale 15.265